Chengdu Easton Biopharmaceuticals Co., Ltd. (SHA:688513)
44.68
+0.36 (0.81%)
Jul 31, 2026, 3:00 PM CST
-28.53% (1Y)
| Market Cap | 7.79B -28.4% |
| Revenue (ttm) | 1.35B +0.9% |
| Net Income | 274.30M +22.6% |
| EPS | 1.58 +24.4% |
| Shares Out | 174.35M |
| PE Ratio | 28.27 |
| Forward PE | 26.28 |
| Dividend | 0.49 (1.10%) |
| Ex-Dividend Date | Jun 2, 2026 |
| Volume | 2,388,446 |
| Open | 44.33 |
| Previous Close | 44.32 |
| Day's Range | 44.32 - 46.08 |
| 52-Week Range | 40.25 - 80.48 |
| Beta | 0.02 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 21, 2026 |